Viewing Study NCT01090427

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2026-03-28 @ 6:44 PM
Study NCT ID: NCT01090427
Status: COMPLETED
Last Update Posted: 2015-01-29
First Post: 2010-03-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ustekinumab View
None Injection View
None CNTO 1275 View
None Stelara View
None Pediatric psoriasis View
None Adolescents View